- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Telangana to Launch Real-Time Digital Drug Safety Alert System

Hyderabad: In a significant move aimed at strengthening drug safety surveillance, the Telangana Drugs Control Administration (DCA) is planning to introduce a real-time digital alert mechanism to ensure faster communication of drug safety warnings and quality-related advisories.
Once implemented, the new system will enable alerts to be issued on the same day a drug is flagged, replacing the existing process that often leads to delays of 15 to 20 days due to reliance on central portals and periodic circulars. The initiative is expected to help curb the circulation of unsafe medicines and protect public health.
At present, drug alerts are largely disseminated through the Central Drugs Standard Control Organisation (CDSCO) portal and monthly communications, which slows down the process of informing stakeholders about not of standard quality (NSQ) drugs. The proposed real-time alert system is designed to immediately notify all concerned parties, allowing quicker action such as freezing stocks and withdrawing affected medicines from the market.
Under the new framework, alerts are expected to be shared through SMS, email, or mobile-based platforms, covering a wide network of stakeholders including around 48,000 drug retailers, nearly 760 manufacturers and wholesalers, and field-level drug inspectors across Telangana. The move is intended to ensure that critical information reaches the ground without delay, reducing the risk of patients consuming substandard or unsafe medicines.
The initiative is being spearheaded by the Drugs Control Administration Telangana, which has acknowledged that delays in communication can have serious public health implications. Faster alerts would enable regulators and sellers to act immediately once a drug fails quality checks, thereby minimizing potential harm.
The DCA has also highlighted challenges related to limited manpower and infrastructure. Currently, the state has only one drug testing laboratory with the capacity to analyse about 5,000 to 6,000 samples annually, against a desired target of 12,000 samples. To address this gap, proposals have been submitted to establish regional drug testing laboratories in places such as Warangal, Nizamabad, Mahabubnagar, and Nalgonda, along with plans to recruit additional drug inspectors, reports Times of India.
M. Pharm (Pharmaceutics)
Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

